申请人:Boehringer Ingelheim International GmbH
公开号:US20170050952A1
公开(公告)日:2017-02-23
The present invention relates to compounds of formula (I)
wherein R
1
, R
2
, and Z
−
have one of the meanings as indicated in the specification or a pharmaceutically acceptable salt thereof, to the use of compounds of formula (I) as a medicament, to pharmaceutical composition comprising at least one compound of formula (I), as well as to medicament combinations containing one or more compounds of formula (I).
本发明涉及式(I)的化合物,其中R1、R2和Z-具有规范中指定的含义或其药学上可接受的盐,以及化合物(I)作为药物的使用,包括至少一个化合物(I)的制药组合物,以及含有一种或多种化合物(I)的药物组合。